Digital Health Archives

What You Should Know: – Veta Health and Indiana-based Interactive Digital Solutions (IDS) announced their strategic partnership to expand IDS’s virtual care offerings through an exclusive reseller agreement. – The adoption of telehealth and virtual care has surged since the Covid-19 pandemic and the demand for solutions that extend beyond virtual visits is high. The partnership enables hospitals and health systems to contract with a single organization to provide a … [Read more…] about IDS Taps Veta Health to Expand Virtual Care Offerings

What You Should Know: – Surgo Health, a new healthcare technology company dedicated to personalized care announced its official launch in Washington, D.C. – Formed as a public benefits company (PBC), Surgo Health is building on the analytics and proprietary data assets from Surgo Ventures and is developing a revolutionary socio-behavioral analytics platform and generating novel, real-world data to enable a greater understanding of the complex factors that influence how individuals engage … [Read more…] about Surgo Health Launches RWD-Driven Socio-Behavioral Analytics Platform

What You Should Know: – Ryse Health, a healthcare technology company that’s committed to pursuing a world free from chronic diseases and raising the bar on Type 2 Diabetes care raises $6.5M in Series A funding led by Route 66 Ventures. The round also included support from W Health and Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield. – The company plans to use the funding to enable Ryse to continue to grow its team, strengthen its business operations, partner … [Read more…] about Ryse Health Secures $6.5M for Type 2 Diabetes Care

What You Should Know: – Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month at participating retail pharmacies. – The historic price cut makes it easier to access Lily insulin for Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable … [Read more…] about Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

What You Should Know: – Progyny, a fertility benefits company pioneering value-based care, announced that they have partnered with the Detroit Pistons, to provide comprehensive, equitable family building care for employees and their families. – Through this partnership, the Detroit Pistons will have access to equitable and comprehensive family building care that its diverse workforce requires. Comprehensive, Value-Based Family Building Care With Progyny, Detroit Pistons … [Read more…] about Detroit Pistons Selects Progyny for Value-Based Family Building Care

What You Should Know: – Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a higher risk of serious or chronic disease. – Reveal solutions surface previously undiscovered insights in readily available clinical data that can help provider organizations deliver greater clinical value for patients and more financial value to the organization. Early … [Read more…] about Mayo’s Lucem Health Launches AI-Driven Early Disease Detection Platform

What You Should Know: – PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions. – PathGroup currently supports more than 15,000 referring physicians and over 200 hospital … [Read more…] about PathGroup Expands Operations with Proscia Concentriq Dx

Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that data accessible for researchers. Unfortunately, the majority of clinical data is based on the same clinical sites and makes conclusions off a limited range of data points. Clinical trials often exclude minorities, rare disease subtypes and other underrepresented populations. Changing the way we gather and share clinical data isn’t easy. Hospitals, biobanks and … [Read more…] about Why Clinical Data Research Needs a Makeover in 2023

What You Should Know: – Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology. – Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology. – … [Read more…] about Tempus, Pfizer Partner to Advance Oncology Therapeutic Development

What You Should Know: – Stratasys Ltd. today announced they have signed another agreement with RICOH USA to provide on-demand 3D-printed anatomic models for clinical settings. – The demand for additive manufacturing within the healthcare industry is continuously growing, and according to Grandview Research, the global healthcare additive manufacturing market size was valued at USD 1.6 billion in 2021 and is expected to expand at a compound annual growth rate of 22.6% from 2022 to 2030. … [Read more…] about Stratasys, Ricoh Partner to Provide On-Demand 3D-Printed Anatomic Models for Hospitals and Clinics